TAM
Tocqueville Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.1M | Sell |
61,102
-24,827
| -29% | -$13M | 0.49% | 55 |
|
2025
Q1 | $54.5M | Buy |
+85,929
| New | +$54.5M | 0.89% | 23 |
|
2018
Q1 | – | Sell |
-10,138
| Closed | -$3.81M | – | 859 |
|
2017
Q4 | $3.81M | Sell |
10,138
-240
| -2% | -$90.2K | 0.04% | 365 |
|
2017
Q3 | $4.64M | Sell |
10,378
-282
| -3% | -$126K | 0.05% | 329 |
|
2017
Q2 | $5.24M | Hold |
10,660
| – | – | 0.06% | 285 |
|
2017
Q1 | $4.13M | Sell |
10,660
-4,735
| -31% | -$1.83M | 0.05% | 325 |
|
2016
Q4 | $5.65M | Buy |
15,395
+130
| +0.9% | +$47.7K | 0.07% | 260 |
|
2016
Q3 | $6.14M | Buy |
15,265
+2,725
| +22% | +$1.1M | 0.07% | 257 |
|
2016
Q2 | $4.38M | Sell |
12,540
-890
| -7% | -$311K | 0.05% | 308 |
|
2016
Q1 | $4.84M | Sell |
13,430
-11,390
| -46% | -$4.11M | 0.06% | 282 |
|
2015
Q4 | $13.5M | Sell |
24,820
-270
| -1% | -$147K | 0.18% | 151 |
|
2015
Q3 | $11.7M | Buy |
25,090
+8,445
| +51% | +$3.93M | 0.16% | 178 |
|
2015
Q2 | $8.49M | Buy |
16,645
+325
| +2% | +$166K | 0.1% | 227 |
|
2015
Q1 | $7.37M | Buy |
16,320
+5
| +0% | +$2.26K | 0.09% | 250 |
|
2014
Q4 | $6.69M | Sell |
16,315
-890
| -5% | -$365K | 0.07% | 276 |
|
2014
Q3 | $6.2M | Sell |
17,205
-225
| -1% | -$81.1K | 0.07% | 259 |
|
2014
Q2 | $4.92M | Buy |
17,430
+500
| +3% | +$141K | 0.05% | 316 |
|
2014
Q1 | $5.08M | Buy |
16,930
+100
| +0.6% | +$30K | 0.07% | 252 |
|
2013
Q4 | $4.63M | Buy |
16,830
+1,635
| +11% | +$450K | 0.06% | 264 |
|
2013
Q3 | $4.75M | Buy |
15,195
+5,770
| +61% | +$1.81M | 0.06% | 305 |
|
2013
Q2 | $2.12M | Buy |
+9,425
| New | +$2.12M | 0.03% | 410 |
|